These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3688595)

  • 1. Effectiveness of commercially available aqueous activated charcoal products.
    Krenzelok EP; Heller MB
    Ann Emerg Med; 1987 Dec; 16(12):1340-3. PubMed ID: 3688595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large surface area activated charcoal and the inhibition of aspirin absorption.
    Dillon EC; Wilton JH; Barlow JC; Watson WA
    Ann Emerg Med; 1989 May; 18(5):547-52. PubMed ID: 2719366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adsorption of salicylates by a milk chocolate-charcoal mixture.
    Eisen TF; Grbcich PA; Lacouture PG; Shannon MW; Woolf A
    Ann Emerg Med; 1991 Feb; 20(2):143-6. PubMed ID: 1996795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated charcoal surface area and its role in multiple-dose charcoal therapy.
    Ilkhanipour K; Yealy DM; Krenzelok EP
    Am J Emerg Med; 1993 Nov; 11(6):583-5. PubMed ID: 8240556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preadministration of activated charcoal and aspirin absorption.
    McKinney PE; Gillilan R; Watson WA
    J Toxicol Clin Toxicol; 1992; 30(4):549-56. PubMed ID: 1433426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption.
    Keller RE; Schwab RA; Krenzelok EP
    Ann Emerg Med; 1990 Jun; 19(6):654-6. PubMed ID: 2188536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlative studies of the hypocholesterolemic effect of a highly activated charcoal.
    Tishler PV; Winston SH; Bell SM
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):799-806. PubMed ID: 3441164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination.
    Ho JL; Tierney MG; Dickinson GE
    J Clin Pharmacol; 1989 Apr; 29(4):366-9. PubMed ID: 2723125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo comparison of the adsorption capacity of "superactive charcoal" and fructose with activated charcoal and fructose.
    Chung DC; Murphy JE; Taylor TW
    J Toxicol Clin Toxicol; 1982 Apr; 19(2):219-24. PubMed ID: 7109011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
    Neuvonen PJ; Elfving SM; Elonen E
    Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of multiple-dose activated charcoal on the absorption of orally administered salicylate in a simulated toxic ingestion model.
    Barone JA; Raia JJ; Huang YC
    Ann Emerg Med; 1988 Jan; 17(1):34-7. PubMed ID: 3337412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin.
    Mathur LK; Jaffe JM; Colaizzi JL; Moriarty RW
    Am J Hosp Pharm; 1976 Jul; 33(7):717-9. PubMed ID: 941924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approach.
    Modi NB; Veng-Pedersen P; Wurster DE; Berg MJ; Schottelius DD
    Pharm Res; 1994 Feb; 11(2):318-23. PubMed ID: 8165195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
    Curtis RA; Barone J; Giacona N
    Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
    Levy G; Soda DM; Lampman TA
    Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible adsorption (desorption) of aspirin from activated charcoal.
    Filippone GA; Fish SS; Lacouture PG; Scavone JM; Lovejoy FH
    Arch Intern Med; 1987 Aug; 147(8):1390-2. PubMed ID: 3632148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal.
    Olsen KM; Ma FH; Ackerman BH; Stull RE
    Pharmacotherapy; 1993; 13(3):229-32. PubMed ID: 8100628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective single blinded randomised controlled trial of two orally administered activated charcoal preparations.
    Boyd R; Hanson J
    J Accid Emerg Med; 1999 Jan; 16(1):24-5. PubMed ID: 9918281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.